KalVista Pharmaceuticals (KALV) Surges 90% on Merck Deal

October 10, 2017 8:10 AM EDT Send to a Friend
KalVista Pharmaceuticals (NASDAQ: KALV) shares are trading up 93% in the pre-open ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login